Two very different studies have recently been published, which indicate that use of intravenous PPIs as an adjunct to endoscopic hemostasis might effectively prevent recurrent ulcer bleeding. What do these studies add to our current knowledge, and what are their practical implications for gastroenterologists?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kang, J. Y., Elders, A., Majeed, A., Maxwell, J. D. & Bardhan, K. D. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland, 1982–2002. Aliment. Pharmacol. Ther. 24, 65–79 (2006).
Elmunzer, B. J., Young, S. D., Inadomi, J. M., Schoenfeld, P. & Laine, L. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am. J. Gastroenterol. 103, 2625–2632 (2008).
Labenz, J. et al. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study. Gut 40, 36–41 (1997).
Kovacs, T. O. Management of upper gastrointestinal bleeding. Curr. Gastroenterol. Rep. 10, 535–542 (2008).
Leontiadis, G. I., Sharma, V. K. & Howden, C. W. Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials. Mayo Clin. Proc. 82, 286–296 (2007).
Sung, J. J. et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann. Intern. Med. 150, 455–464 (2009).
Ono, S. et al. Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial. Endoscopy 41, 299–303 (2009).
Uedo, N. et al. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am. J. Gastroenterol. 102, 1610–1616 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J. Labenz is a consultant, serves on the speakers' bureau and receives research support from AstraZeneca and serves on the speakers' bureau for Eisai.
A. Leodolter is a consultant and serves on the speakers' bureau for AstraZeneca and serves on the speakers' bureau for Eisai.
Rights and permissions
About this article
Cite this article
Leodolter, A., Labenz, J. Adjuvant PPIs to prevent major ulcer bleeds. Nat Rev Gastroenterol Hepatol 6, 446–447 (2009). https://doi.org/10.1038/nrgastro.2009.120
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2009.120
